E-LIB Suche - Ergebnisse für: Takebe, Naoko

1

Phase I/II Study of Combined BCL-xL and MEK Inhibition with..:

Corcoran, Ryan B. ; Do, Khanh T. ; Kim, Jeong E....
Clinical Cancer Research. 30 (2024) 9 - p. 1739-1749 , 2024

Link: https://doi.org/10.1158/..

2

The effect of liver dysfunction on the pharmacokinetic disp..:

Dunn, Allison ; Takebe, Naoko ; Chen, Alice...
Cancer Chemotherapy and Pharmacology. , 2024

Link: https://doi.org/10.1007/..

3

Emerging advances in defining the molecular and therapeutic..:

Sen, Triparna ; Takahashi, Nobuyuki ; Chakraborty, Subhamoy...
Nature Reviews Clinical Oncology. , 2024

Link: https://doi.org/10.1038/..

4

Phase II study of vemurafenib in children and young adults ..:

Nelson, Marie V ; Kim, AeRang ; Williams, P Mickey...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

5

Blood-based multi-cancer detection: A state-of-the-art upda..:

Farooq, Maria ; Leevan, Elyse ; Ahmed, Jibran...
Current Problems in Cancer. 48 (2024) - p. 101059 , 2024

Link: https://doi.org/10.1016/..

6

Olaparib for childhood tumors harboring defects in DNA dama..:

Glade Bender, Julia L ; Pinkney, Kerice ; Williams, Paul M...
The Oncologist. 29 (2024) 7 - p. 638-e952 , 2024

Link: https://doi.org/10.1093/..

7

A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2..:

Maldonado, Edward ; Rathmell, W. Kimryn ; Shapiro, Geoffrey I....
Cancer Research Communications. , 2024

Link: https://doi.org/10.1158/..

8

Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-2..:

Arakawa, Yasuhiro ; Jo, Ukhyun ; Kumar, Suresh...
Cancer Research Communications. 4 (2024) 3 - p. 834-848 , 2024

Link: https://doi.org/10.1158/..

9

Phase 1 trial of navitoclax and sorafenib in patients with ..:

Emiloju, Oluwadunni E. ; Yin, Jun ; Koubek, Emily...
Investigational New Drugs. 42 (2024) 1 - p. 127-135 , 2024

Link: https://doi.org/10.1007/..

10

Rethinking Oncologic Treatment Strategies with Interleukin-:

Ko, Brian ; Takebe, Naoko ; Andrews, Omozusi..
Cells. 12 (2023) 9 - p. 1316 , 2023

Link: https://doi.org/10.3390/..

11

The NCI-MATCH trial: lessons for precision oncology:

O'Dwyer, Peter J. ; Gray, Robert J. ; Flaherty, Keith T....
Nature Medicine. 29 (2023) 6 - p. 1349-1357 , 2023

Link: https://doi.org/10.1038/..

12

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 a..:

Chi, Susan N ; Yi, Joanna S ; Williams, P Mickey...
JNCI: Journal of the National Cancer Institute. 115 (2023) 11 - p. 1355-1363 , 2023

Link: https://doi.org/10.1093/..

13

Early drug development in solid tumours: analysis of Nation..:

Chihara, Dai ; Lin, Ruitao ; Flowers, Christopher R...
The Lancet. 400 (2022) 10351 - p. 512-521 , 2022

Link: https://doi.org/10.1016/..

14

Population Pharmacokinetics of Z‐Endoxifen in Patients With..:

Koubek, Emily J. ; Ralya, Andrew T. ; Larson, Thomas R....
The Journal of Clinical Pharmacology. 62 (2022) 9 - p. 1121-1131 , 2022

Link: https://doi.org/10.1002/..

15

ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II..:

Sloan, Andrew E. ; Nock, Charles J. ; Ye, Xiaobu...
Journal of Neuro-Oncology. 161 (2022) 1 - p. 33-43 , 2022

Link: https://doi.org/10.1007/..